Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
Specifically, the ELIXA (lixisenatide) trial studied patients with T2DM who had recent acute coronary syndrome and found that the addition of lixisenatide to conventional therapy did not result in a significant difference in cardiovascular endpoints relative to placebo (Table 1) [56]
Association of bile duct and gallbladder diseases with the use of incretin-based drugs in patients with type 2 diabetes mellitus
Focusing on a customer-centric approach, TRIVENI INTERCHEM PVT
This means that our former runner-up here, PureBulk, is the undisputed top pick in our estimation
US$ 23.22
US$ 20.05
US$ 22.15
US$ 21.35
US$ 29.03
US$ 20.94
US$ 25.91
